沃森生物: 关于公司部分高级管理人员变动的公告

Group 1 - The company has appointed new vice presidents, Li Wei and Liu Yuran, to enhance its organizational structure and respond to market changes [1][2] - Li Wei will oversee key product production and quality management, while Liu Yuran will handle major project financing, legal compliance, and audit supervision [2] - The appointments aim to build a professional, youthful, international, and company-specific management team to improve operational standards and business development [1][2] Group 2 - Liu Yuran will resign from his position as the board secretary, with the board chairman, Li Yunchun, temporarily taking over the role until a new secretary is appointed [3][4] - The board has proposed to appoint Yan Ye as the new board secretary, pending his qualification certification [3][4] - Yan Ye has a background in capital operations and has held various managerial positions, indicating his capability for the role [7][8] Group 3 - The company acknowledges the contributions of Liu Yuran and Shi Jing during their tenure and expresses gratitude for their efforts [5] - Shi Jing will continue to serve as the general manager of the bacterial vaccine business unit and other managerial roles after his resignation [4][5] - The company emphasizes compliance with relevant laws and regulations throughout the appointment and resignation processes [2][3][4]